Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Lackmann

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Science Signaling|April 17, 2008
Eph, a protein family coming of age: more confusion, insight, or complexity?Martin Lackmann, Andrew W Boyd
Growth Factors (Chur, Switzerland)|July 16, 2005
"Eph receptor signalling; dimerisation just isn't enough"Christopher J Vearing, Martin Lackmann
IUBMB Life|July 14, 2005
Eph-modulated cell morphology, adhesion and motility in carcinogenesisSabine H Wimmer-Kleikamp, Martin Lackmann
Critical Reviews in Oncogenesis|April 5, 2012
Targeting of EPH receptor tyrosine kinases for anticancer therapyEva Nievergall, Thomas Saunders, Martin Lackmann
Seminars in Cell & Developmental Biology|January 21, 2012
Concepts and consequences of Eph receptor clusteringPeter W Janes, Eva Nievergall, Martin Lackmann
Cell Adhesion & Migration|December 9, 2014
The role of proteases in regulating Eph/ephrin signalingLakmali Atapattu, Martin Lackmann, Peter W Janes
Cellular and Molecular Life Sciences : CMLS|December 29, 2011
Eph-dependent cell-cell adhesion and segregation in development and cancerEva Nievergall, Martin Lackmann, Peter W Janes
Current Cancer Drug Targets|September 11, 2008
Eph/ephrin signalling and function in oncogenesis: lessons from embryonic developmentPeter W Janes, Samantha Adikari, Martin Lackmann
Nature Reviews. Drug Discovery|January 1, 2014
Therapeutic targeting of EPH receptors and their ligandsAndrew W Boyd, Perry F Bartlett, Martin Lackmann
Protein Science : a Publication of the Protein Society|April 3, 2007
Crystal structure of the human ephrin-A5 ectodomainDimitar Nikolov, Chen Li, Martin Lackmann, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Science Signaling|April 17, 2008
Eph, a protein family coming of age: more confusion, insight, or complexity?Martin Lackmann, Andrew W Boyd
Growth Factors (Chur, Switzerland)|July 16, 2005
"Eph receptor signalling; dimerisation just isn't enough"Christopher J Vearing, Martin Lackmann
IUBMB Life|July 14, 2005
Eph-modulated cell morphology, adhesion and motility in carcinogenesisSabine H Wimmer-Kleikamp, Martin Lackmann
Critical Reviews in Oncogenesis|April 5, 2012
Targeting of EPH receptor tyrosine kinases for anticancer therapyEva Nievergall, Thomas Saunders, Martin Lackmann
Seminars in Cell & Developmental Biology|January 21, 2012
Concepts and consequences of Eph receptor clusteringPeter W Janes, Eva Nievergall, Martin Lackmann
Cell Adhesion & Migration|December 9, 2014
The role of proteases in regulating Eph/ephrin signalingLakmali Atapattu, Martin Lackmann, Peter W Janes
Cellular and Molecular Life Sciences : CMLS|December 29, 2011
Eph-dependent cell-cell adhesion and segregation in development and cancerEva Nievergall, Martin Lackmann, Peter W Janes
Current Cancer Drug Targets|September 11, 2008
Eph/ephrin signalling and function in oncogenesis: lessons from embryonic developmentPeter W Janes, Samantha Adikari, Martin Lackmann
Nature Reviews. Drug Discovery|January 1, 2014
Therapeutic targeting of EPH receptors and their ligandsAndrew W Boyd, Perry F Bartlett, Martin Lackmann
Protein Science : a Publication of the Protein Society|April 3, 2007
Crystal structure of the human ephrin-A5 ectodomainDimitar Nikolov, Chen Li, Martin Lackmann, et al.
Pageof 4